You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer

Price: EUR 27.50